139 Al-Laith, M., Jasenecova, M., Abraham, S., Bosworth, A., Bruce, I.N., Buckley, C.D., Ciurtin, C., D’Agostino, M.A., Emery, P., Gaston, H., et al. (2019). Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials 20, 429. 10.1186/s13063-019-3403-7. Israeli, E., Grotto, I., Gilburd, B., Balicer, R.D., Goldin, E., Wiik, A., and Shoenfeld, Y. (2005). Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54, 1232-6. 10.1136/gut.2004.060228. Zholudev, A., Zurakowski, D., Young, W., Leichtner, A., and Bousvaros, A. (2004). Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am. J. Gastroenterol. 99, 2235-41. 10.1111/j.1572-0241.2004.40369.x. Mitsuyama, K., Niwa, M., Takedatsu, H., Yamasaki, H., Kuwaki, K., Yoshioka, S., Yamauchi, R., Fukunaga, S., Torimura, T. (2016). Antibody markers in the diagnosis of inflammatory bowel disease. World J. Gastroenterol. 22, 1304-10. 10.3748/wjg.v22.i3.1304. Machiels, K., Pozuelo Del Rio, M., Martinez-De la Torre, A., Xie, Z., Pascal Andreu, V., Sabino, J., Santiago, A., Campos, D., Wolthuis, A., D’Hoore, A., et al. (2020). Early Postoperative Endoscopic Recurrence in Crohn’s Disease Is Characterised by Distinct Microbiota Recolonisation. J. Crohns Colitis 14, 1535-1546. 10.1093/ ecco-jcc/jjaa081. Zhuang, X., Tian, Z., Li, N., Mao, R., Li, X., Zhao, M., Xiong, S., Zeng, Z., Feng, R., and Chen, M. (2021). Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn’s Disease: A Systematic Review. Front. Med. (Lausanne) 7, 615858. 10.3389/fmed.2020.615858. Hosomi, S., Watanabe, K., Nishida, Y., Yamagami, H., Yukawa, T., Otani, K., Nagami, Y., Tanaka, F., Taira, K., Kamata, N., et al. (2018). Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis. Inflamm. Bowel Dis. 24, 1307-1315. 10.1093/ibd/izy005. Pezhouh, M.K., Miller, J.A., Sharma, R., Borzik, D., Eze, O., Waters, K., Westerhoff, M.A., Parian, A.M., Lazarev, M.G., and Voltaggio, L. (2018). Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization. Human Pathol. 82, 187-192. 10.1016/j.humpath.2018.08.001. Marchix, J., Goddard, G., and Helmrath, M.A. (2018). Host-Gut Microbiota Crosstalk in Intestinal Adaptation. Cell. Mol. Gastroenterol. Hepatol. 6, 149-162. 10.1016/j.jcmgh.2018.01.024. Palm, N.W., de Zoete, M.R., Cullen, T.W., Barry, N.A., Stefanowski, J., Hao, L., Degnan, P.H., Hu, J., Peter, I., Zhang, W., et al. (2014). Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010. 10.1016/j.cell.2014.08.006. Kau, A.L., Planer, J.D., Liu, J., Rao, S., Yatsunenko, T., Trehan, I., Manary, M.J., Liu, T.C., Stappenbeck, T.S., Maleta, K.M., et al. (2015). Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci. Transl. Med. 7, 276ra24. 10.1126/ scitranslmed.aaa4877. Bunker, J.J., Drees, C., Watson, A.R., Plunkett, C.H., Nalger, C.R., Schneewind, O., Eren, A.M., and Bendelac, A. (2019). B cell superantigens in the human intestinal microbiota. Sci. Transl. Med. 11, eaau9356. 10.1126/ scitranslmed.aau9356. 47 48 49 50 51 52 53 54 55 56 57 58 The antibody epitope repertoire in IBD
RkJQdWJsaXNoZXIy MjY0ODMw